Accurate identification of CUP-LCP with subsequent access to MGT and ICIs based on molecular profiling and PD-L1 status has the potential to improve outcomes for a large subgroup of CUP patients, given lung is the most commonly identified primary tumour at autopsy [67]. This evidence concerns the gene CD274 and neoplasm.